The impact of clinical response to anti-CTLA4 treatment on overall survival (OS) in metastatic melanoma (MM).
Xiaolan Feng
No relevant relationships to disclose
Michael Smylie
No relevant relationships to disclose
Tina Cheng
No relevant relationships to disclose
Jose Gerard Monzon
No relevant relationships to disclose
Richard M. Lee-Ying
No relevant relationships to disclose